Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-01-31 Sale |
2022-02-02 4:32 pm |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
8,195 | $7.58 | $62,118 | 490,025 (Direct) |
View |
2022-01-04 Sale |
2022-01-07 08:38 am |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
46,968 | $9.15 | $429,757 | 298,220 (Direct) |
View |
2020-12-14 Purchase |
2020-12-15 5:27 pm |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
10,000 | $18.5 | $185,000 | 229,117 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-31 Option Award |
2025-02-04 11:49 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
96,377 | $0 | 96,377 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 5:34 pm |
N/A 2034-06-05 |
Allogene Therapeutics Inc. | ALLO | Barrett Elizabeth A. Director |
191,082 | $0 | 191,082 (Direct) |
View |
2024-01-31 Option Award |
2024-02-02 7:04 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
87,615 | $0 | 87,615 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 5:03 pm |
N/A 2033-06-13 |
Allogene Therapeutics Inc. | ALLO | Barrett Elizabeth A. Director |
116,120 | $0 | 116,120 (Direct) |
View |
2023-01-31 Exercise |
2023-02-02 3:40 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
18,333 | $0 | 640,025 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 3:40 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
300,000 | $0 | 640,025 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:57 pm |
N/A 2032-06-15 |
Allogene Therapeutics Inc. | ALLO | Barrett Elizabeth A. Director |
71,070 | $0 | 71,070 (Direct) |
View |
2022-01-31 Exercise |
2022-02-02 4:32 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
18,333 | $0 | 490,025 (Direct) |
View |
2022-01-31 Option Award |
2022-02-02 4:32 pm |
N/A 2032-01-31 |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
150,000 | $0 | 490,025 (Direct) |
View |
2022-01-03 Exercise |
2022-01-07 08:38 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
105,689 | $0 | 298,220 (Direct) |
View |
2021-07-30 Option Award |
2021-08-03 5:32 pm |
N/A 2031-07-30 |
Allogene Therapeutics Inc. | ALLO | Barrett Elizabeth A. Director |
63,385 | $0 | 63,385 (Direct) |
View |
2020-06-03 Exercise(A) |
2021-07-12 6:59 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
61,652 | $0 | 1,205,551 (Direct) |
View |
2021-01-03 Exercise |
2021-05-21 1:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
13,807 | $0 | 355,188 (Direct) |
View |
2021-05-19 Tax Withholding |
2021-05-21 1:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
3,425 | $17.51 | 355,188 (Direct) |
View |
2021-01-31 Option Award |
2021-02-02 2:54 pm |
N/A 2031-01-31 |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
190,000 | $0 | 190,000 (Direct) |
View |
2020-12-04 Exercise |
2020-12-04 4:35 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
61,652 | $0 | 333,613 (Direct) |
View |
Ownership |
2020-11-20 7:05 pm |
N/A N/A |
Lifesci Acquisition II Corp. | LSAQ | Barrett Elizabeth A. Director |
0 | $0 | 6,000 (Direct) |
View |
2020-05-12 Exercise |
2020-05-14 1:07 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
35,229 | $0 | 333,613 (Direct) |
View |